FDA
-
-
-
-
-
-
-
Omega Therapeutics (OMGA) Granted Orphan Drug Designation for OTX-2002
-
-
-
-
-
-
-
Omega Therapeutics Presents New Preclinical Data Supporting the First Epigenomic Controller, OTX-2002, as a Potential Therapeutic Approach in Hepatocellular Carcinoma at the ESMO 2022 World Congress o
-
-
-
-
-
-
-
Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

